A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin

研究微生物群在肠病因学中的作用的斑马鱼模型

基本信息

  • 批准号:
    9207745
  • 负责人:
  • 金额:
    $ 28.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The human gastrointestinal tract houses large and complex communities of microorganisms that are important for normal health, but can also contribute to diseases such as gastrointestinal cancer. In this proposal we will use a zebrafish model to investigate how factors produced by gut microbes interact with host genetic factors to drive the progression of intestinal cancer. We will make use of zebrafish lines that are predisposed to intestinal cancer due to over-activation of the Wnt signaling pathway, chronic inflammation, or loss of DNA repair mechanisms, all of which are commonly associated with gastrointestinal cancers in humans. In our first aim we will characterize a number of secreted proteins, produced by both human and zebrafish-associated bacteria, that modulate host programs associated with gastrointestinal cancer development, including epithelial cell proliferation and inflammation. We will determine whether the pro-proliferative proteins interacts synergistically with cancer-prone genetic backgrounds to disrupt normal programs of intestinal epithelial renewal and cause hyperplasia, and furthermore whether the anti-inflammatory proteins confer protection against hyperplasia. In our second aim we will characterize a transgenic zebrafish line that expresses the bacterial oncogene, CagA, from the stomach cancer-associated pathogen Helicobacter pylori. We will determine the host genetic programs that are activated during the progression of these transgenic fish to hyperplasia and cancer, and we will test which of these pathways are required for CagA's carcinogenic properties. We will also test whether CagA expression alters the intestinal microbial community in ways that promote intestinal pathology. In our third aim we will investigate the microbial etiology behind an outbreak of spontaneous intestinal cancers in our zebrafish facility, which we have shown to be transmissible. We will use the experimental framework of transmissible disease to identify microbes associated with intestinal pathology. We will employ our cancer- prone zebrafish lines to characterize the carcinogenic potential of disease-associated microbial communities and of individual candidate microbes. This research will provide new insight into the mechanisms by with intestinal microbes contribute to cancer development and will ultimately lead to new approaches to diagnose, treat and prevent gastrointestinal cancers in humans.
描述(由申请人提供):人体胃肠道内有大量复杂的微生物群落,这些微生物对正常健康很重要,但也可能导致胃肠道癌等疾病。在这项提案中,我们将使用斑马鱼模型来研究肠道微生物产生的因子如何与宿主遗传因子相互作用,以推动肠癌的进展。我们将利用由于Wnt信号通路过度激活、慢性炎症或DNA修复机制缺失而易患肠癌的斑马鱼品系,所有这些都与人类胃肠道癌症有关。在我们的第一个目标中,我们将表征由人类和斑马鱼相关细菌产生的许多分泌蛋白,这些分泌蛋白调节与胃肠道癌症发展相关的宿主程序,包括上皮细胞增殖和炎症。我们将确定促增殖蛋白是否与癌症易感遗传背景协同作用,破坏肠上皮更新的正常程序并引起增生,以及抗炎蛋白是否提供针对增生的保护。在我们的第二个目标中,我们将描述一个转基因斑马鱼线,表达细菌癌基因,CagA,从胃癌相关的病原体幽门螺杆菌。我们将确定在这些转基因鱼的增生和癌症的进展过程中被激活的宿主遗传程序,我们将测试这些途径中的哪一个是CagA的致癌特性所必需的。我们还将测试CagA表达是否以促进肠道病理学的方式改变肠道微生物群落。在我们的第三个目标中,我们将调查一种细菌感染背后的微生物病因学。 在我们的斑马鱼设施中爆发了自发性肠癌,我们已经证明了这种癌症是可以传播的。我们将使用传染性疾病的实验框架来识别与肠道病理学相关的微生物。我们将使用我们的癌症易感斑马鱼系来表征疾病相关微生物群落和单个候选微生物的致癌潜力。这项研究将为肠道微生物促进癌症发展的机制提供新的见解,并最终导致诊断,治疗和预防人类胃肠道癌症的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen J Guillemin其他文献

Karen J Guillemin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen J Guillemin', 18)}}的其他基金

Graduate Training Grant in Genetics
遗传学研究生培训补助金
  • 批准号:
    10627213
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
  • 批准号:
    10227108
  • 财政年份:
    2018
  • 资助金额:
    $ 28.99万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10468035
  • 财政年份:
    2018
  • 资助金额:
    $ 28.99万
  • 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
  • 批准号:
    10468041
  • 财政年份:
    2018
  • 资助金额:
    $ 28.99万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10227103
  • 财政年份:
    2018
  • 资助金额:
    $ 28.99万
  • 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
  • 批准号:
    8997473
  • 财政年份:
    2014
  • 资助金额:
    $ 28.99万
  • 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
  • 批准号:
    9318540
  • 财政年份:
    2014
  • 资助金额:
    $ 28.99万
  • 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
  • 批准号:
    8629573
  • 财政年份:
    2014
  • 资助金额:
    $ 28.99万
  • 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
  • 批准号:
    9118193
  • 财政年份:
    2014
  • 资助金额:
    $ 28.99万
  • 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
  • 批准号:
    8652710
  • 财政年份:
    2014
  • 资助金额:
    $ 28.99万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 28.99万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了